Andrew Atz to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications Andrew Atz has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0.480
-
Translating clinical trials into clinical practice: a survey assessing the potential impact of the Pediatric Heart Network Infant Single Ventricle Trial. Cardiol Young. 2017 Sep; 27(7):1265-1270.
Score: 0.125
-
Lessons learned from a pediatric clinical trial: the Pediatric Heart Network angiotensin-converting enzyme inhibition in mitral regurgitation study. Am Heart J. 2011 Feb; 161(2):233-40.
Score: 0.082
-
Surgical management of complete atrioventricular septal defect: associations with surgical technique, age, and trisomy 21. J Thorac Cardiovasc Surg. 2011 Jun; 141(6):1371-9.
Score: 0.081
-
Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation. 2010 Jul 27; 122(4):333-40.
Score: 0.079
-
Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle. Am Heart J. 2009 Jan; 157(1):37-45.
Score: 0.071
-
Factors affecting growth in infants with single ventricle physiology: a report from the Pediatric Heart Network Infant Single Ventricle Trial. J Pediatr. 2011 Dec; 159(6):1017-22.e2.
Score: 0.021
-
The Fontan patient: inconsistencies in medication therapy across seven pediatric heart network centers. Pediatr Cardiol. 2010 Nov; 31(8):1219-28.
Score: 0.020